Back

sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure, independent of Mineralocorticoid Receptor Antagonists treatment.

27 May 2018 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2018

About the speaker

Photo
Doctor Philippe Rouet

Rangueil Hospital of Toulouse, Toulouse (France)

30 More presentations in this session

Presentation thumbnail
Doctor Y. Chia (Singapore, SG)
Abstract Slides
Presentation thumbnail
Mr V. Martinez Mateo (Alcazar de San Juan, ES)
Abstract Slides
Presentation thumbnail
Professor A. Grupper (Beer Yakov, IL)
Abstract Slides
Presentation thumbnail
Doctor O. Manintveld (Rotterdam, NL)
Abstract Slides
Presentation thumbnail
Doctor E. Cabrera Romero (Murcia, ES)
Abstract

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Epidemiology, Prognosis, Outcome

The Event

Event poster

Heart Failure 2018

27 May 2018 08:30 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources